Narya Capital, a venture fund founded in 2019, operates out of Ohio and Illinois. Specializing in Seed to Series C stages, the fund focuses on BioTech, Healthcare, Life Science, Apps, Health & Wellness, Consumer, InsurTech, Information Technology, and Medical Device sectors. Partnered with Jd Vance, Narya Capital has invested in 12 companies like Kriya Therapeutics, Hallow, and Chapter, with one successful exit. The firm describes itself as a thesis-driven investor supporting early-stage startups. For more information, visit their website at www.naryavc.com.